New England Biolabs (U.K.) Limited
Registered name: NEW ENGLAND BIOLABS (U.K.) LIMITED
New England Biolabs (U.K.) Limited made £36m revenue and £1.8m profit in the year to 30 Sep 2025. read from filing text
New England Biolabs (U.K.) Limited’s revenue grew 1% to £36m in the year to 30 Sep 2025, with £1.8m profit and 44 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Hitchin; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Hitchin, East of England
- Age
- 33 yrs · since 1993
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate and ultimate parent company and controlling party is New England Biolabs Inc. for which group financial statements are prepared. The company is incorporated and registered in the United ”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Sep 2022 | 30 Sep 2023 | 30 Sep 2024 | 30 Sep 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £51.9m | £35m | £35.7m | £36m |
| Cost of sales | — | £28.7m | £29.5m | £29.2m |
| Gross profit | — | — | £6.3m | £6.8m |
| Operating profit | — | — | £1.7m | £1.6m |
| Profit before tax | — | — | £2.1m | £1.8m |
| Profit after tax | £2m | £987k | — | — |
| Profit (best available) | £2m | £987k | £2.1m | £1.8m |
| Staff costs | £3.4m | £3m | £3.1m | £3.7m |
| Employees (average) | 37 | 40 | 43 | 44 |
| Ratios | ||||
| Profit margin | 3.8% | 2.8% | 5.8% | 4.9% |
| Gross margin | — | — | 17.5% | 18.8% |
| Revenue per employee | £1.4m | £875k | £831k | £818k |
| Profit per employee | £53k | £24.7k | £48k | £40.1k |
| Growth (year on year) | ||||
| Revenue growth | — | ▼32.6% | ▲2% | ▲0.8% |
| Profit growth | — | ▼49.6% | ▲109.3% | ▼14.4% |
| Headcount growth | — | ▲8.1% | ▲7.5% | ▲2.3% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £12.4m | £17m | £3.6m | £2.5m |
| Net assets | £15.2m | £16.2m | £10.6m | £7.9m |
| Current assets | £17.2m | £23.2m | — | — |
| Cash from operations | £5.8m | £4.1m | — | — |
| Source | FullAccounts · bulk data Oct 2024 | FullAccounts · bulk data Oct 2024 | FullAccounts · bulk data Mar 2025 | FullAccounts · bulk data Jan 2026 |
How the business works
- Profit margin
- 4.9%
- Profit ÷ revenue.
- Gross margin
- 18.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £818k
- Revenue ÷ average employees.
- Profit per employee
- £40.1k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼26%
- Now £7.9m
- Cash at bank
- ▼32%
- Now £2.5m
- Headcount
- ▲2%
- Now 44
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Attends LimitedWakefield · Wholesale of pharmaceutical goods
- Revenue
- £35.9m
- Profit
- £635k
- Staff
- 23
- Knox Pharmaceuticals LimitedRipon · Wholesale of pharmaceutical goods
- Revenue
- £37.1m
- Profit
- £3.8m
- Staff
- 38
- Target Healthcare LimitedGlasgow · Wholesale of pharmaceutical goods
- Revenue
- £37.3m
- Profit
- £2.2m
- Staff
- 131
- Beta Pharmaceuticals LimitedWitham · Wholesale of pharmaceutical goods
- Revenue
- £34.3m
- Profit
- £120k
- Staff
- 61
- Dexcel-Pharma LimitedCoventry · Wholesale of pharmaceutical goods
- Revenue
- £39.1m
- Profit
- £3.7m
- Staff
- 25
- Ims Euro LimitedStockport · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £5.5m
- Staff
- 83
Sources
Latest figures from FullAccounts for the year to 30 Sep 2025 (profit £1.8m), from the Companies House accounts bulk data published Jan 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.